Clinical outcomes of FOLFIRINOX in locally advanced pancreatic cancer: A single center experience.

被引：0
|
作者：
Lee, Jongchan
Lee, Jong-Chan
Kim, Hyoung Woo
Kim, Jaihwan
Hwang, Jin-Hyeok
机构：
[1] Seoul Natl Univ, Bundang Hosp, Seongnam Si, South Korea
[2] Seoul Natl Univ, Bundang Hosp, Seongnam, South Korea
[3] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Coll Med, Seongnam, South Korea
[4] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Coll Med, Seongnam Si, South Korea
[5] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Seongnam, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 04期
关键词：
D O I：
10.1200/JCO.2017.35.4_suppl.480
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
480
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Therapy of locally advanced pancreatic cancer with FOLFIRINOX
    Strobel, O.
    Buechler, M. W.
    CHIRURG, 2016, 87 (08): : 699 - 699
  • [22] Single institution experience with FOLFIRINOX in advanced pancreatic cancer (PC)
    Gunturu, Krishna Soujanya
    Thumar, Jaykumar Ranchodbhai
    Hochster, Howard S.
    Stein, Stacey
    Yao, Xiaopan
    Cong, Xiangyu
    Lacy, Jill
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [23] Irreversible electroporation for locally advanced pancreatic cancer: A single-center experience
    Tsuchiya, Takayoshi
    Sugimoto, Katsutoshi
    Kamada, Kentaro
    Fujita, Mitsuru
    Yamamoto, Kenjiro
    Matsunami, Yukitoshi
    Nagakawa, Yuichi
    Hosokawa, Yuichi
    Tsuchida, Akihiko
    Moriyasu, Fuminori
    Itoi, Takao
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 : 199 - 199
  • [24] Neoadjuvant Treatment in Locally Advanced Pancreatic Cancer (LAPC) Patients with FOLFIRINOX or Gemcitabine NabPaclitaxel: A Single-Center Experience and a Literature Review
    Napolitano, Fabiana
    Formisano, Luigi
    Giardino, Alessandro
    Girelli, Roberto
    Servetto, Alberto
    Santaniello, Antonio
    Foschini, Francesca
    Marciano, Roberta
    Mozzillo, Eleonora
    Carratu, Anna Chiara
    Cascetta, Priscilla
    De Placido, Pietro
    De Placido, Sabino
    Bianco, Roberto
    CANCERS, 2019, 11 (07)
  • [25] FOLFIRINOX in Locally Advanced and Metastatic Pancreatic Cancer: A Single Centre Cohort Study
    Rombouts, S. J.
    Mungroop, T. H.
    Heilmann, M. N.
    van Laarhoven, H. W.
    Busch, O. R.
    Molenaar, I. Q.
    Besselink, M. G.
    Wilmink, J. W.
    JOURNAL OF CANCER, 2016, 7 (13): : 1861 - 1866
  • [26] FOLFIRINOX for locally advanced or metastatic pancreatic cancer: a single institution retrospective review
    Sasaki, Mitsuhito
    Ueno, Hideki
    Makihara, Reiko
    Koga, Futa
    Shiba, Satoshi
    Sakamoto, Yasunari
    Kondo, Shunsuke
    Morizane, Chigusa
    Ikeda, Masafumi
    Okusaka, Takuji
    ANNALS OF ONCOLOGY, 2015, 26 : 120 - 120
  • [27] Single-institution experience with FOLFIRINOX in advanced pancreatic cancer (PC)
    Gunturu, Krishna Soujanya
    Thumar, Jaykumar Ranchodbhai
    Hochster, Howard S.
    Stein, Stacey
    Yao, Xiaopan
    Cong, Xiangyu
    Hahn, Carol
    Kaley, Kristin
    Lacy, Jill
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [28] FOLFIRINOX in locally advanced and metastatic pancreatic cancer.
    Faris, Jason Edward
    Hong, Theodore S.
    McDermott, Shaunagh
    Borger, Darrell R.
    Guimaraes, Alexander R.
    Wo, Jennifer Yon-Li
    Sahani, Dushyant
    Dias, Lauren Elizabeth
    Allen, Jill N.
    Zhu, Andrew X.
    Murphy, Janet E.
    Kwak, Eunice Lee
    Ryan, David P.
    Clark, Jeffrey W.
    Blaszkowsky, Lawrence Scott
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [29] Clinical Outcomes of Conversion Surgery after FOLFIRINOX in Patients with Unresectable Advanced Pancreatic Cancer: A Retrospective Cohort Study at a Single Center
    Mita, Naoki
    Iwashita, Takuji
    Ichikawa, Hironao
    Iwasa, Yuhei
    Uemura, Shinya
    Murase, Katsutoshi
    Shimizu, Masahito
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (13)
  • [30] FOLFIRINOX for the treatment of pancreatic adenocarcinoma: Australian single institute experience.
    Dean, Andrew Peter
    Mulvey, Arthur
    Hayden, Ingrid
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345